WholePanel™ Tests

Harness the power of genome sequencing

WholePanels are expertly curated gene panels that use genome sequencing to offer unparalleled coverage.

This genome sequencing-based method allows clients to experience all of the traditional benefits of whole genome sequencing, including more uniform coverage in targeted genes. Key features include:

Full intronic coverage

Single nucleotide variants

Short tandem repeat screening

If allele expansion cannot be reliably ruled out, further confirmatory diagnostic testing is recommended to provide a definitive diagnosis

Mean coverage 40x across introns and exons

Reliable detection of intragenic deletions and duplications

Includes large-scale CNV events, such as microdeletions and other gene- and chromosomal-level events

WholeCancer^TM Panel (D5238)

Approximately 5-10% of all cancers are hereditary, caused by a gene mutation in the family. This number may be higher in certain cancers like ovarian, with up to 20% being hereditary. Identifying hereditary cancer predisposition allows for proactive medical management to reduce cancer risk, including earlier and more frequent screenings, preventive surgery options, and certain medications that can reduce cancer risk. In individuals with a cancer diagnosis, identifying hereditary cancer allows for the prevention of secondary cancers and testing family members to identify their cancer risk and recommended cancer screenings.

Learn More>